Back to results

CompletedPhase 2

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

NCT01584440

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Phoenix, Arizona, United States

+43 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2012-08-13
Enrollment: 220 participants
Sponsor: Avanir Pharmaceuticals
Purpose: treatment

Locations (44)

Phoenix, Arizona, United States
Sun City, Arizona, United States
Fresno, California, United States
Fullerton, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
San Diego, California, United States
San Francisco, California, United States
Sherman Oaks, California, United States
Temecula, California, United States
Boynton Beach, Florida, United States
Deerfield Beach, Florida, United States
Hialeah, Florida, United States
Miami, Florida, United States
Miami, Florida, United States
Miami, Florida, United States
Ocala, Florida, United States
Orlando, Florida, United States
Sunrise, Florida, United States
Tampa, Florida, United States
West Palm Beach, Florida, United States
West Palm Beach, Florida, United States
Weston, Florida, United States
Elk Grove Village, Illinois, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Summit, New Jersey, United States
Toms River, New Jersey, United States
Orangeburg, New York, United States
Rochester, New York, United States
White Plains, New York, United States
Centerville, Ohio, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Columbus, Ohio, United States
Lakewood, Ohio, United States
Allentown, Pennsylvania, United States
Reading, Pennsylvania, United States
Charleston, South Carolina, United States
Houston, Texas, United States
San Antonio, Texas, United States
Salt Lake City, Utah, United States
Bennington, Vermont, United States
Spokane, Washington, United States

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease — TrialFind